Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance and Re-assessment of the actual benefit following the Transparency Committee conclusions in its opinions of 26 November 2008 and reiterated in its opinion of 21 September 2011.
Clinical Benefit
| Insufficient |
The actual benefit of CHONDROSULF 400 mg capsules and granules is insufficient to justify reimbursement by National Insurance. |
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
aLKp1RVaZDSf4NmU
